Business

Recognition reflects Genpact’s role in catalyzing the private sector as a force for good, bringing together academics, scientists, organizations, and businesses to help reopen the US economy faster with rapid COVID-19 workplace testing.

Genpact was specifically cited for its role in founding the US Rapid Action Consortium, which brings together leading scientists, academics and organizations to help companies navigate the complexities of implementing and operating COVID-19 testing programs at scale to help businesses across the country – large and small – create safer workplaces and communities.

In determining this year’s winners, Fortune looked at companies that have had a positive social impact through activities that are part of their core business strategy. This includes measurable social impact, business results, and how innovative a company’s efforts are relative to others in its industry. Fortune highlighted the work of the Consortium in its award citation, recognizing the challenges that exist in restarting US businesses.

“Fortune’s annual Change the World list celebrates companies that make measurable progress addressing pressing social problems, something that has never been more critical or more needed in today’s incredibly complex global environment,” said Alan Murray, CEO, Fortune. “The list reflects the growing corporate commitment to stakeholder capitalism, with Genpact and all of these named companies leading the way in combining purpose and profit—the best way to assure such programs are sustainable.”

Genpact founded the US Rapid Action Consortium with the Creative Destruction Lab Rapid Screening Consortium (CDL RSC) in Canada, and the COVID Collaborative. Together, these partners leverage thousands of hours of research, vast quantities of data, and insights to make available, as a public good, essential screening protocols that are scalable and can be leveraged by most types of organizations. Staying true to its purpose, “the relentless pursuit of a world that works better for people,” Genpact is using its digital and process expertise in solving complex business challenges for global organizations to help US companies safely return their employees to on-site work environments.

The US Rapid Action Consortium is an expansion of successful work done in Canada by the CDL RSC, of which Genpact also is a founding member. Between the US Rapid Action Consortium and the CDL RSC, Consortium member companies have administered more than 630,000 tests across more than 900 locations. Across locations, the rapid testing program has detected more than 500 asymptomatic individuals, preventing over 22,000 secondary infections from occurring.

“The Consortium was founded on the belief that the private sector is and must be a powerful force for progress in combatting the pandemic,” said Stacy Simpson, global leader of corporate responsibility, diversity, equity, and inclusion, Genpact, and founder and co-chair, US Rapid Action Consortium. “We’re extremely proud that Fortune has recognized the mission and progress of the Rapid Action Consortium. In addition to being a global health crisis, COVID-19 is also an information problem of the size and scale the world has never seen before. As with any complex information problem, the solution requires intelligent use of data and technology, and the right parties to come together to collectively learn, innovate, and rapidly iterate to create impact.”